Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mannatech launches business in South Africa
Mannatech is offering a full range of dietary and glyconutritional products in South Africa. Among these products is the Optimal Health System, which is comprised of Ambrotose complex;
Mannatech is offering a full range of dietary and glyconutritional products in South Africa. Among these products is the Optimal Health System, which is comprised of Ambrotose complex;
Pursuant to the special protocol assessment, this Phase III trial will be a randomized, double-blind, placebo-controlled trial of IMC-1121B plus docetaxel in women with unresectable locally-recurrent or metastatic
The study is being supported by a Small Business Innovative Research grant awarded from the National Institutes of Health. The total amount of the grant, $3 million, will
David Snow Jr., Medco chairman and CEO, said: “We look forward to the next generation of collaboration with UnitedHealth Group, delivering innovative, world-class pharmacy services. This agreement advances
The company has begun dosing healthy volunteers with ATI-9242 in a Phase I safety study being conducted under an investigational new drug application. ARYx expects to complete the
BLISS-52 was initiated in May 2007, and has enrolled and randomized a total of 867 patients at 90 clinical sites in 13 countries, primarily in Asia, South America
The new development program will examine direct (intravesical) administration of LOR-2040 into the bladder as a treatment for superficial or non-invasive bladder cancer. Formal toxicology evaluation, which is
Propel is a pivotal Phase II, international, multi-center, open-label, single-arm study that enrolled patients with relapsed or refractory PTCL who progressed after at least one prior treatment. Patients
The two companies will continue their joint efforts to identify novel small molecule therapeutics with the potential to treat several diseases, including type 2 diabetes and other metabolic
Replidyne took this action to conserve its cash assets and support initiatives that include pursuing strategic transactions and maintaining its research programs. The acute exacerbation of chronic bronchitis